Bicara Therapeutics, Inc. is a clinical-stage biotechnology company and develops biologics engineered to combine the precision of well validated, tumor-targeting antibodies with the power of tumor microenvironment modulators. The company’s bi-functional antibodies are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, offering the potential for synergistic therapeutic impact at the site of the tumor. Its products include BCA101, a first-in-class EGFR/TGF-ß-trap bifunctional antibody in clinical development for multiple tumor types. The company was founded on December 12, 2018 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
55
Frequently Asked Questions
What is Market Cap of Bicara Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Bicara Therapeutics Inc. market cap is $1.23B.
What is the 52-week high for Bicara Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Bicara Therapeutics Inc. 52 week high is $20.25 as of March 17, 2026.
What is the 52-week low for Bicara Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Bicara Therapeutics Inc. 52 week low is $7.80 as of March 17, 2026.
What is Bicara Therapeutics Inc. stock price today?
Bicara Therapeutics Inc. stock price today is $19.32.
What was Bicara Therapeutics Inc. stock price yesterday?
Bicara Therapeutics Inc. stock price yesterday was $19.40.
What is the PE ratio of Bicara Therapeutics Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Bicara Therapeutics Inc.'s P/E ratio is -8.7.
What is the Price-to-Book ratio of Bicara Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Bicara Therapeutics Inc. P/B ratio is 2.6304.
What is the 50-day moving average of Bicara Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Bicara Therapeutics Inc. 50-day moving average is $16.87.
How many employees does Bicara Therapeutics Inc. have?